Healthcare >> CEO Interviews >> October 26, 2004
COLIN W. STEWART is President and Chief Executive Officer of CollaGenex
Pharmaceuticals, Inc. Mr. Stewart joined the company in December 2003
from Muro Pharmaceutical, Inc., where he was President and Chief
Executive Officer. During his five-year tenure in this position he
refocused the company on respiratory and allergy medicines and rebuilt
the franchise through a combination of organic growth, in-licensing and
strategic alliances. A veteran of the pharmaceutical industry, Mr.
Stewart previously served 10 years with the ASTA Medica Group, where he
managed several business units in the United States and internationally.
He began his career in sales and marketing for Winthrop Laboratories,
Ltd., in the United Kingdom and subsequently held a number of positions
of increasing responsibility within the Sterling-Winthrop Group. Profile
technology and products?
Mr. Stewart: CollaGenex is a specialty pharmaceutical company, based
primarily in dentistry and in
